MIA3 was upregulated in bladder urothelial carcinoma (BLCA) and downregulated in thyroid cancer (THCA) and renal chromophobic cell carcinoma (KICH) (Fig. 1A, B). This evidence concerns the gene MIA3 and thyroid gland carcinoma.